Parsons G H, Villablanca A C, Brock J M, Howard R S, Colbert S R, Nichol G M, Chung K F
Department of Medicine, University of California, Davis 95616.
J Appl Physiol (1985). 1992 Jun;72(6):2090-8. doi: 10.1152/jappl.1992.72.6.2090.
Histamine has been shown to mediate features of pulmonary allergic reactions including increased tracheobronchial blood flow. To determine whether the increase in blood flow was due to stimulation of H1- or H2-histamine receptors, we gave histamine base (0.1 micrograms/kg iv) or histamine dihydrochloride as an aerosol (10 breaths of 0.5% "low dose" or 5% "high dose") before and after H1- or H2-receptor antagonists. Blood velocity in the common bronchial branch of the bronchoesophageal artery (Vbr) was continuously measured using a chronically implanted Doppler flow probe. Pretreatment with H2-receptor antagonists cimetidine, ranitidine, or metiamide did not affect the increase in Vbr induced by intravenous histamine [106 +/- 45% (SD)]. Addition of the H1-receptor antagonists diphenhydramine or chlorpheniramine, however, reduced the Vbr response to 16 +/- 22, 21 +/- 28, 23 +/- 23, and 37 +/- 32% of the unblocked responses (P less than 0.05) when intravenous histamine was given at 3, 10, 20, and 30 min, respectively, after the H1 antagonist. At 40, 50, and 60 min the H1-receptor blockade appeared to attenuate, but subsequent continuous infusion of chlorpheniramine (2 mg.kg-1.min-1) then blocked the histamine response for 60 min. Low-dose histamine aerosol did not change mean arterial or pulmonary arterial pressures, cardiac output, or arterial blood gases but increased Vbr transiently from 15.2 +/- 3.4 to 37.6 +/- 8.4 (SE) cm/s. After chlorpheniramine, the Vbr response to histamine, 16.3 +/- 2.2 to 22.6 +/- 3.6 cm/s, was significantly reduced (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
组胺已被证明可介导肺部过敏反应的特征,包括气管支气管血流量增加。为了确定血流量增加是否是由于H1或H2组胺受体的刺激,我们在给予H1或H2受体拮抗剂之前和之后,静脉注射组胺碱(0.1微克/千克)或雾化给予二盐酸组胺(0.5%“低剂量”或5%“高剂量”,呼吸10次)。使用长期植入的多普勒血流探头连续测量支气管食管动脉共同支气管分支中的血流速度(Vbr)。用H2受体拮抗剂西咪替丁、雷尼替丁或甲硫米特预处理并不影响静脉注射组胺引起的Vbr增加[106±45%(标准差)]。然而,加入H1受体拮抗剂苯海拉明或氯苯那敏后,当分别在给予H1拮抗剂后3、10、20和30分钟静脉注射组胺时,Vbr反应分别降至未阻断反应的16±22%、21±28%、23±23%和37±32%(P<0.05)。在40、50和60分钟时,H1受体阻断似乎减弱,但随后连续输注氯苯那敏(2毫克·千克-1·分钟-1)则在60分钟内阻断了组胺反应。低剂量组胺气雾剂不会改变平均动脉压或肺动脉压、心输出量或动脉血气,但会使Vbr短暂从15.2±3.4增加到37.6±8.4(标准误)厘米/秒。给予氯苯那敏后,组胺引起的Vbr反应从16.3±2.2增加到22.6±3.6厘米/秒,显著降低(P<0.05)。(摘要截断于250字)